Pregnancy outcome after gestational exposure to metronidazole: A prospective controlled cohort study

Teratology

Volumn 63, Issue 5, 2001, Pages 186-192

  Diav Citrin, Orna ^a   Shechtman, Svetlana ^a   Gotteiner, Talma ^b   Arnon, Judy ^a   Ornoy, Asher ^a,b  

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ADULT; ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTI-INFECTIVE AGENTS; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; METRONIDAZOLE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; RISK FACTORS; TERATOGENS;

EID: 0035013557     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.1033     Document Type: Article

References (34)

1. Lack of evidence for cancer due to use of metronidazole
2. Safety of metronidazole in pregnancy: A meta-analysis
3. Midline facial defect as a teratogenic effect of metronidazole
4. Is metronidazole teratogenic? A meta-analysis
5. Experimental studies on teratology of metronidazole
6. A population based case-control teratologic study of oral metronidazole treatment during pregnancy
7. Meta-analysis. Spurious precision? Meta-analysis of observational studies
8. Metronidazole
9. Possible metronidazole teratogenicity and clefting
10. Need for inclusion and exclusion criteria for the structural abnormalities recorded in children born from exposed pregnancies
11. The effect of the preparation "trichomonacide" on pregnancy in experimental animals
12. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice
13. Problems of using data from teratology information services (TIS) to identify putative teratogens
14. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study
15. Metronidazole treatment in pregnancy
16. Recurrent (habitual) abortions: Incidence, epidemiology and possible prevention
17. Is benzodiazepine use during pregnancy really teratogenic?
18. More on data from Teratogen Information Systems (TIS)
19. Metronidazole in pregnancy
20. Prenatal use of metronidazole and birth defects: No association
21. Metronidazole use in obstetrics and gynecology: A review
22. Trichomonas vaginalis. V. Further observations on metronidazole (including infant follow-up)
23. Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic and teratogenic potential
24. Pregnancy outcomes after first-trimester vaginitis drug therapy
25. Introduction of lung tumors and malignant lymphomas in mice by metronidazole
26. Experimental induction of hepatomas, mammary tumors and other tumors with metronidazole in non-inbred sas:MRC(W1)BR rats
27. Pregnancy, trichomoniasis and metronidazole
28. Metronidazole in obstetric practice
29. Safety of metronidazole during pregnancy: A cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women
30. Drugs used in the chemotherapy of protozoal infections: Trypanosomiasis, leishmaniasis, amebiasis, giardiasis, trichomoniasis, and other protozoal infections
31. The mutagenic action of nitroimidazoles. I. Metronidazole, nimorazole, dimetridazole and ronidazole